NCT05560386

Brief Summary

The number of youth with type 2 diabetes in the U.S. is projected to increase by a staggering 49 percent by 2050, with higher rates among minority youth. The Diabetes Prevention Program (DPP) is recognized as a sentinel study demonstrating the effectiveness of lifestyle interventions for diabetes prevention among pre-diabetic adults but has not yet been replicated in youth. In addition, such intensive interventions are often not sustainable in high risk communities with limited resources. One strategy that has been successfully employed in adults from such communities is peer based health education. However, there have been no peer led interventions in ethnic minority teens and no interventions focused specifically on weight loss for diabetes prevention. Another challenge identified in existing youth health intervention programs is keeping youth engaged to enhance program participation and impact. One potential strategy is the use of mobile technologies (text messaging, mobile applications, social media) to support weight management programs, but to date use of such technologies has largely not been studied in youth. The Principal Investigator's NIH Mentored Patient-Oriented Research Career Development Award (K23) aimed to use CBPR to develop and pilot test a peer-led diabetes prevention intervention incorporating mobile health technologies for at-risk adolescents. Based on results of focus groups which explored strategies for using peer educators and mHealth tools as part of a group lifestyle change program, the researchers did not find existing tools with all the features and functionalities required by users. The investigators therefore began working with teen stakeholders to create a new text messaging platform to support participants as the teens complete the intervention. This R03 research proposal aims to bring together clinical, technology and community experts to further develop and evaluate the mobile health platform. This will provide important pilot data to refine and disseminate the intervention for a larger RCT to be tested in a future R01. Specific Aims:

  1. 1.Synthesize real-time data and analytics and conduct user interface (UI) testing to refine and enhance features of the prototype text messaging platform.
  2. 2.Investigate the potential for the developed platform to be used as an adjunct to a group educational intervention by examining whether level of use, user satisfaction, and degree of engagement with the platforms modifies behavioral and clinical outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 26, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 29, 2022

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

December 29, 2023

Completed
Last Updated

December 29, 2023

Status Verified

December 16, 2023

Enrollment Period

1.7 years

First QC Date

September 26, 2022

Results QC Date

September 20, 2023

Last Update Submit

December 22, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Body Mass Index (BMI)

    Maintenance or reduction of BMI after completion of the virtual diabetes prevention program. BMI is a person's weight in kilograms divided by the square of height in meters. A high BMI can indicate high body fatness and may lead to health problems.

    baseline

  • Body Mass Index (BMI)

    Maintenance or reduction of BMI after completion of the virtual diabetes prevention program. BMI is a person's weight in kilograms divided by the square of height in meters. A high BMI can indicate high body fatness and may lead to health problems.

    end of study at 3 months

Secondary Outcomes (57)

  • Number of Participants Who Were Responsive to Interactive 2-way Messages

    12 Weeks

  • Number of Participants Who Were Engaged Every Week

    12 weeks

  • Level of Engagement

    Over 12 weeks of time

  • Hemoglobin A1c

    baseline

  • Hemoglobin A1c

    end of study at 3 months

  • +52 more secondary outcomes

Study Arms (2)

Text messaging program

EXPERIMENTAL

Enrolled participants received the pilot text messaging program.

Behavioral: Text messaging

Virtual peer education

EXPERIMENTAL

Enrolled participants received a virtual peer education diabetes prevention program.

Behavioral: Virtual workshop

Interventions

Text messagingBEHAVIORAL

text messaging content to support diabetes prevention.

Text messaging program

virtual workshop content to support diabetes prevention.

Virtual peer education

Eligibility Criteria

Age13 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • For Aim 1 (user interface testing):
  • Ages 13-19 years;
  • English speaking with English or Spanish speaking parent/guardian;
  • Affiliated with East Harlem.
  • For Aim 2 (virtual workshop):
  • Ages 13-19 years;
  • English speaking with English or Spanish speaking parent/guardian;
  • Affiliated with East Harlem;
  • Overweight/obese based on measured body mass index;
  • prediabetic based on hemoglobin A1c

You may not qualify if:

  • \- Medical or developmental conditions which would make it difficult to participate in a virtual group educational program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Icahn School of Medicine at Mount Sinai

New York, New York, 10029, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Results Point of Contact

Title
Nita Vangeepuram
Organization
Icahn School of Medicine at Mount Sinai

Study Officials

  • Nita Vangeepuram

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 26, 2022

First Posted

September 29, 2022

Study Start

August 1, 2020

Primary Completion

March 31, 2022

Study Completion

March 31, 2022

Last Updated

December 29, 2023

Results First Posted

December 29, 2023

Record last verified: 2023-12-16

Data Sharing

IPD Sharing
Will not share

Locations